Activating p53 Abolishes Self-Renewal of Quiescent Leukemic Stem Cells in Residual CML Disease

Scientists demonstrated that the regulatory programs of quiescent leukemic stem cell (LSC) in chronic phase chronic myeloid leukemia (CML) are similar to that of embryonic stem cells, pointing to a role for wild type p53 in LSC self-renewal.